State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance

References

• Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the ‘common’ neurologic disorders? Neurology. 2007;68:326–37.
   PubMed Web of Science ®Google Scholar
• Chio A, Logrosino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118–30.
   PubMed Web of Science ®Google Scholar
• Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68:1002–7.
   PubMed Web of Science ®Google Scholar
• Gundogdu B, Al-Lahham T, Kadlubar F, Spencer H, Rudnicki SA. Racial differences in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:114–8.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Wagner L, Archer NP, Williamson D, Henry JP, Schiffer R, Jackson CE.Prevalence of amyotrophic lateral sclerosis in Texas, 1998–2003. Tex Med. 2012;108:e1.
   Google Scholar
• Turabelidze G, Zhu B, Schootman M, Malone J, Horowitz S, Weidinger J, et al. An epidemiological investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998–2002. Neurotoxicology. 2008;29:81–6.
   PubMed Web of Science ®Google Scholar
• Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ.Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925–1998. Neurology. 2002;59:280–2.
   PubMed Web of Science ®Google Scholar
• Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, et al. Prevalence of amyotrophic lateral sclerosis – United States, 2010–2011. MMWR Surveill Summ. 2014;63 (Suppl 7):1–14.
   PubMed Web of Science ®Google Scholar
• Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health. 2012;75:28–30.
   PubMed Web of Science ®Google Scholar
• Kaye WE, Sanchez M, Wu J. Feasibility of creating a National ALS Registry using administrative data in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:433–9.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revised criteria for the diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10). Geneva: World Health Organization 1992.
   Google Scholar
• U.S. Census Population estimates. [Online]. 2014. Available from: URL:http://www.census.gov/popest/data/national/totals/2013/index.html. Accessed on October 15, 2014.
   Google Scholar
• Microsoft Excel [computer program]. Redmond, Washington: Microsoft; 2010.
   Google Scholar
• IBM SPSS Statistics for Windows, Version 19.0 [computer program]. Armonk, NY: IBM Corp; 2010.
   Google Scholar
• Gardner MJ, Altman DG. Confidence intervals rather than p-values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed). 1986;292:746–50.
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Leigh PN.Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
   PubMed Web of Science ®Google Scholar
• Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ, The Netherlands ALS Consortium. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. J Neurol Sci. 1997;152(Suppl 1):S10–7.
   PubMed Web of Science ®Google Scholar
• Logrosino G, Traynor B, Hardiman O, Chio A, Mitchell D, Swingler R, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• McGuire V, Longsreth WT, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology. 1996;47:571–3.
   PubMed Web of Science ®Google Scholar
• Ragonese P, Cellura E, Aridon P, D'amelio M, Spartaro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13:284–7.
   PubMed Web of Science ®Google Scholar
• Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.
   PubMed Web of Science ®Google Scholar
• Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W.Effects of Demographic Factors on Survival Time after a Diagnosis of Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2015;44:114–20.
   PubMed Web of Science ®Google Scholar
• Cellura E, Spataro R, Taiello A, La Bella V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery. 2012;114:550–4.
   PubMed Web of Science ®Google Scholar
• Khishchenko N, Allen K, Coffman C, Kasaeskis E, Lindquist J, Morgenlander J, et al. Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler. 2010;11:125–32.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population based study. Arch Neurol. 2000; 57:1171–6.
   PubMed Web of Science ®Google Scholar
• O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al.Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2.
   PubMed Web of Science ®Google Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
   PubMed Web of Science ®Google Scholar
• Gibson SB, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L.Familial clustering of ALS in a population based resource. Neurology. 2014;82:17–22.
   Google Scholar
• Strong M, Grace G, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein L, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioral syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
   PubMed Web of Science ®Google Scholar
• Gordon P, Delgadillo D, Piquad A, Bruneteau G, Pradat P, Salachas F, et al. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance. Amyotroph Lateral Scler. 2011;12:372–8.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Ringholz G, Appel S, Bradshaw M, Cooke N, Mosnik, D, Schulz P. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, et al.Cognitive correlates in amyotrophic lateral sclerosis: a population based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86:168–73.
   Google Scholar
• Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, et al.; ALS COSMOS Study Group. ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:192–203.
   PubMed Web of Science ®Google Scholar
• Belsh JM. Diagnostic challenges in ALS. Neurology. 1999;53(Suppl 5):S26–30; discussion S35–6.
   PubMed Web of Science ®Google Scholar